Myasthenia gravis: clinical, immunological, and therapeutic advances.
We give an update on clinical, immunological, and therapeutic advances in the field of myasthenia gravis, including a summary of suggested therapeutic recommendations.
Romi
F
F
Department of Neurology, Haukeland University Hospital, Bergen, Norway. fredrik.romi@haukeland.no
Gilhus
N E
NE
Aarli
J A
JA
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000150:complications / Q000276:immunology / Q000628:therapy; D010956:Plasmapheresis; D013934:Thymectomy
D002800:Cholinesterase Inhibitors; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents